DE2415763A1 - Neue benzochinolizine, verfahren zu ihrer herstellung und diese enthaltende mittel - Google Patents

Neue benzochinolizine, verfahren zu ihrer herstellung und diese enthaltende mittel

Info

Publication number
DE2415763A1
DE2415763A1 DE2415763A DE2415763A DE2415763A1 DE 2415763 A1 DE2415763 A1 DE 2415763A1 DE 2415763 A DE2415763 A DE 2415763A DE 2415763 A DE2415763 A DE 2415763A DE 2415763 A1 DE2415763 A1 DE 2415763A1
Authority
DE
Germany
Prior art keywords
benzo
dihydro
oxo
quinolizine
tetrazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE2415763A
Other languages
German (de)
English (en)
Inventor
David Edmund Bays
Gwynn Pennant Ellis
Heulwen Moira Ridgway
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allen and Hanburys Ltd
Original Assignee
Allen and Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allen and Hanburys Ltd filed Critical Allen and Hanburys Ltd
Publication of DE2415763A1 publication Critical patent/DE2415763A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2415763A 1973-04-05 1974-04-01 Neue benzochinolizine, verfahren zu ihrer herstellung und diese enthaltende mittel Pending DE2415763A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1627973A GB1433151A (en) 1973-04-05 1973-04-05 Benzo-ij-quinolizines

Publications (1)

Publication Number Publication Date
DE2415763A1 true DE2415763A1 (de) 1974-10-17

Family

ID=10074459

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2415763A Pending DE2415763A1 (de) 1973-04-05 1974-04-01 Neue benzochinolizine, verfahren zu ihrer herstellung und diese enthaltende mittel

Country Status (14)

Country Link
US (1) US3917608A (US07612075-20091103-C00064.png)
JP (1) JPS5024296A (US07612075-20091103-C00064.png)
AT (1) AT330180B (US07612075-20091103-C00064.png)
AU (1) AU6720074A (US07612075-20091103-C00064.png)
BE (1) BE813158A (US07612075-20091103-C00064.png)
CA (1) CA1015758A (US07612075-20091103-C00064.png)
CH (1) CH602722A5 (US07612075-20091103-C00064.png)
DE (1) DE2415763A1 (US07612075-20091103-C00064.png)
FR (1) FR2230355B1 (US07612075-20091103-C00064.png)
GB (1) GB1433151A (US07612075-20091103-C00064.png)
IE (1) IE39101B1 (US07612075-20091103-C00064.png)
LU (1) LU69756A1 (US07612075-20091103-C00064.png)
NL (1) NL7404719A (US07612075-20091103-C00064.png)
ZA (1) ZA741860B (US07612075-20091103-C00064.png)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0119779A1 (en) * 1983-03-17 1984-09-26 Riker Laboratories, Incorporated 8-Alkoxy-6,7-dihydro-5-methyl-9-fluoro-1-oxo-1H,5H-benzo(ij)quinolizine-2-carboxylic acids
EP0207287A2 (de) * 1985-06-04 1987-01-07 Bayer Ag Indolinderivate, Verfahren zu ihrer Herstellung und diese Indolinderivate enthaltende kosmetische Lichtschutzmittel
WO2006002421A3 (en) * 2004-06-24 2006-09-21 Vertex Pharma Modulators of atp-binding cassette transporters
US8354427B2 (en) 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
US8410274B2 (en) 2005-12-28 2013-04-02 Vertex Pharmaceuticals Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
EP2502914A3 (en) * 2004-06-24 2013-12-04 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
RU2525115C2 (ru) * 2004-06-24 2014-08-10 Вертекс Фармасьютикалз Инкорпорейтед Способ модуляции транспортеров атф-связывающей кассеты
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
US9701639B2 (en) 2014-10-07 2017-07-11 Vertex Pharmaceuticals Incorporated Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator
US9751839B2 (en) 2009-03-20 2017-09-05 Vertex Pharmaceuticals Incorporated Process for making modulators of cystic fibrosis transmembrane conductance regulator
US10272046B2 (en) 2012-02-27 2019-04-30 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US10646481B2 (en) 2008-08-13 2020-05-12 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051247A (en) * 1975-04-14 1977-09-27 Riker Laboratories, Inc. Method of using 7-hydroxy-benzo[ij]quinolizine-2-carboxylic acid derivatives
AT377986B (de) * 1978-08-31 1985-05-28 Otsuka Pharma Co Ltd Verfahren zur herstellung von neuen piperazinylbenzoheterozyklischen verbindungen und ihren pharmazeutisch annehmbaren salzen
JPS5540616A (en) * 1978-09-14 1980-03-22 Otsuka Pharmaceut Co Ltd Preparation of benzo-hetero-compound
AT377987B (de) * 1979-04-11 1985-05-28 Otsuka Pharma Co Ltd Verfahren zur herstellung von neuen piperazinylbenzoheterozyklischen verbindungen und ihren pharmazeutisch annehmbaren salzen
US4400386A (en) * 1981-11-06 1983-08-23 Riker Laboratories, Inc. Antimicrobial derivatives of 8-amino and 8-aminomethyl benzo(ij)quinolizine
US4650804A (en) * 1984-03-30 1987-03-17 Fujisawa Pharmaceutical Co., Ltd. Quinolizinone compounds and pharmaceutical composition comprising the same, useful as anti-ulcerative and anti-allergic agents
CA1266484A (en) * 1984-12-14 1990-03-06 Ronald Edward Mac Leay Tert-octylhydrazine, its salts and derivatives
WO1997030999A1 (en) * 1996-02-21 1997-08-28 Darwin Discovery Limited Quinolones and their therapeutic use
US5792774A (en) * 1996-02-21 1998-08-11 Chiroscience Limited Quinolones and their therapeutic use
AU710876B2 (en) * 1996-02-21 1999-09-30 Darwin Discovery Limited Quinolones and their therapeutic use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3728350A (en) * 1967-07-17 1973-04-17 Lilly Co Eli 1-(2-carboxyphenyl)-5,7-dimethoxy-3,4-dihydrocarbostyril intermediates for acronycis
US3793328A (en) * 1969-11-03 1974-02-19 Upjohn Co 8benzoyl 1,2,3,4 tetrahydroquinoline
BE789822A (fr) * 1971-10-08 1973-04-06 Allen & Hanburys Ltd Nouveaux composes heterocycliques
BE793524A (fr) * 1971-12-30 1973-06-29 Riker Laboratories Inc Acides benzoquinolizine-carboxyliques et leurs derives

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0119779A1 (en) * 1983-03-17 1984-09-26 Riker Laboratories, Incorporated 8-Alkoxy-6,7-dihydro-5-methyl-9-fluoro-1-oxo-1H,5H-benzo(ij)quinolizine-2-carboxylic acids
EP0207287A2 (de) * 1985-06-04 1987-01-07 Bayer Ag Indolinderivate, Verfahren zu ihrer Herstellung und diese Indolinderivate enthaltende kosmetische Lichtschutzmittel
EP0207287A3 (de) * 1985-06-04 1988-05-11 Bayer Ag Indolinderivate, Verfahren zu ihrer Herstellung und diese Indolinderivate enthaltende kosmetische Lichtschutzmittel
US7495103B2 (en) 2004-06-24 2009-02-24 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US8614327B2 (en) 2004-06-24 2013-12-24 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US8101767B2 (en) 2004-06-24 2012-01-24 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US8324242B2 (en) 2004-06-24 2012-12-04 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
US8354427B2 (en) 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
WO2006002421A3 (en) * 2004-06-24 2006-09-21 Vertex Pharma Modulators of atp-binding cassette transporters
EP2502914A3 (en) * 2004-06-24 2013-12-04 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
EP2530075A3 (en) * 2004-06-24 2014-12-24 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US8629162B2 (en) 2004-06-24 2014-01-14 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US8741925B2 (en) 2004-06-24 2014-06-03 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US10662192B2 (en) 2004-06-24 2020-05-26 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
RU2525115C2 (ru) * 2004-06-24 2014-08-10 Вертекс Фармасьютикалз Инкорпорейтед Способ модуляции транспортеров атф-связывающей кассеты
US9090619B2 (en) 2004-06-24 2015-07-28 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US8829204B2 (en) 2004-06-24 2014-09-09 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US8410274B2 (en) 2005-12-28 2013-04-02 Vertex Pharmaceuticals Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US11291662B2 (en) 2005-12-28 2022-04-05 Vertex Pharmaceuticals Incorporated Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US9139530B2 (en) 2005-12-28 2015-09-22 Vertex Pharmaceuticals Incorporated Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US9670163B2 (en) 2005-12-28 2017-06-06 Vertex Pharmaceuticals Incorporated Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US9931334B2 (en) 2005-12-28 2018-04-03 Vertex Pharmaceuticals Incorporated Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US10537565B2 (en) 2005-12-28 2020-01-21 Vertex Pharmaceuticals Incorporated Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US8754224B2 (en) 2005-12-28 2014-06-17 Vertex Pharmaceuticals Incorporated Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US11564916B2 (en) 2008-08-13 2023-01-31 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US10646481B2 (en) 2008-08-13 2020-05-12 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US9751839B2 (en) 2009-03-20 2017-09-05 Vertex Pharmaceuticals Incorporated Process for making modulators of cystic fibrosis transmembrane conductance regulator
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
US10272046B2 (en) 2012-02-27 2019-04-30 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US11147770B2 (en) 2012-02-27 2021-10-19 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US11752106B2 (en) 2012-02-27 2023-09-12 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US9701639B2 (en) 2014-10-07 2017-07-11 Vertex Pharmaceuticals Incorporated Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator

Also Published As

Publication number Publication date
ZA741860B (en) 1975-02-26
US3917608A (en) 1975-11-04
LU69756A1 (US07612075-20091103-C00064.png) 1975-06-16
GB1433151A (en) 1976-04-22
AU6720074A (en) 1975-10-02
ATA277074A (de) 1975-09-15
CH602722A5 (US07612075-20091103-C00064.png) 1978-07-31
AU474838B2 (US07612075-20091103-C00064.png) 1976-08-05
FR2230355B1 (US07612075-20091103-C00064.png) 1977-05-06
NL7404719A (US07612075-20091103-C00064.png) 1974-10-08
CA1015758A (en) 1977-08-16
IE39101B1 (en) 1978-08-02
BE813158A (fr) 1974-10-01
FR2230355A1 (US07612075-20091103-C00064.png) 1974-12-20
JPS5024296A (US07612075-20091103-C00064.png) 1975-03-15
IE39101L (en) 1974-10-05
AT330180B (de) 1976-06-25

Similar Documents

Publication Publication Date Title
DE2415763A1 (de) Neue benzochinolizine, verfahren zu ihrer herstellung und diese enthaltende mittel
DE69006799T2 (de) Spirocyclische antipsychotische Mittel.
EP0005205B1 (de) Substituierte 5,6-Dimethylpyrrolo(2,3-d)pyrimidine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE3001328C2 (US07612075-20091103-C00064.png)
DE69716062T2 (de) Benzofuran-derivate und deren verwendung
DE2407744A1 (de) Chinolin-3-carboxamidotetrazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
DD229990A5 (de) Verfahren zur herstellung von neuen 2-piperazino-pteridine
DE3004750A1 (de) Neue heterotricyclische derivate, verfahren zu deren herstellung, ihre verwendung als arzneimittel und sie enthaltenden pharmazeutischen zusammensetzungen
DE2802493C2 (US07612075-20091103-C00064.png)
DE2410852A1 (de) Neue chinoxalin-2-carboxamidotetrazolderivate, verfahren zu ihrer herstellung und diese enthaltende mittel
DE2263100C2 (de) 5,5-Dimethyl-8-(3-methyl-2-octyl)-10-[4-(piperidino)-butyryloxy]-2-(2-propinyl)-1,2,3,4-tetrahydro-5H-[1]-benzopyrano[3,4-d]pyridin, Verfahren zu dessen Herstellung und die Verbindung enthaltende Arzneimittel
EP0006114B1 (de) 7-Methoxy-5-oxo-5H-thiazolo(2,3-b)chinazolin-2-carbonsäure und deren pharmazeutisch verwendbare Salze. Verfahren zu deren Herstellung und sie enthaltende Arzneimittel
DE10043659A1 (de) Arylpiperazinderivate
AT371461B (de) Verfahren zur herstellung neuer benzopyranderivate und deren salze
DD236928A5 (de) Verfahren zur herstellung neuer 1,2,4-triazolo-carbamate
DE2519059A1 (de) Neue aminoderivate von 6-phenylpyrazolo(3.4-b)pyridinen
DE1919381B2 (de) Heterocyclische Verbindungen und Verfahren zu deren Herstellung
DE2722416A1 (de) Neue thiazolo-pyridine
EP0233483A2 (de) Pyrrolo[1,2-a][4,1]benzoxazepine, Verfahren zur ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie therapeutische Verwendung
EP0139993A2 (de) Chinazolinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2415767A1 (de) Neue naphthyridinderivate, verfahren zu ihrer herstellung und diese enthaltende mittel
EP0273168A1 (de) Triazaspirodecanylmethylindolon-Derivate
DE68919507T2 (de) 2-Pyridylmethylthio-Derivate und antiulzerierendes Mittel.
DE2334782A1 (de) 12-acyl-5,6,11,12-tetrahydrodibenzo eckige klammer auf b,f eckige klammer zu eckige klammer auf 1,4 eckige klammer zu diazocinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0137993B1 (de) Neue 11-Piperazinyl-5H-imidazo[2,1-c][1,4]benzodiazepine, Verfahren zu ihrer Herstellung und Zwischenprodukte und erstere enthaltende Arzneimittel

Legal Events

Date Code Title Description
OHJ Non-payment of the annual fee